Indonesia national agency for drug and food control, BPOM, approved QDENGA for use in individuals 6 to 45 years of age
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the OlympiA trial, in these patients
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
The pandemic has taught us that health is not the exclusive responsibility of only the Union Health Ministry but jointly addressed by various Ministries at the centre and through state governments
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
The hospital is being constructed at an estimated cost of around Rs. 6,000 crore and will provide healthcare facilities to the people of Faridabad and the entire NCR region
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
Therapy recently approved in Canada under the brand name KORSUVA
Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country
Subscribe To Our Newsletter & Stay Updated
